Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sanofi
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of B-cell non Hodgkin's lymphoma
Relapsed or refractory after standard treatments and with no curative option with conventional therapy (Patients having undergone stem cell transplantation may be included)
CD19 positive disease by flow cytometry or immunohistochemistry
You may not be if
Burkitt's lymphoma, Lymphoblastic lymphoma, Chronic lymphocytic leukemia (Small lymphocytic lymphoma may be included)
Evidence of cerebral or meningeal involvement by lymphoma
Patients without bi-dimensionally measurable disease
ECOG performance status \> 2
Life expectancy less than 3 months
Chemotherapy or radiation therapy or other investigational agents within 4 weeks prior to entering the study
Previous radioimmunotherapy within 12 weeks
Known anaphylaxis to infused proteins
HIV, HBV and HCV positivity
Poor kidney, liver and bone marrow functions
Any serious active disease or co-morbid condition, which, in the opinion of the principle investigator, will interfere with the safety or the compliance with the study
Pregnant or breast-feeding women
Patients with reproductive potential without effective birth control methods
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
